Global 'epidemic' of gullet cancer seems to have started in UK in 1950s

August 22, 2012

The global "epidemic" of one type of gullet cancer (adenocarcinoma) seems to have started in the UK during the 1950s, sparked by some as yet unknown, but common, factor, suggests research published online in Gut.

There are two distinct types of gullet (oesophageal) cancer—squamous and , the latter typically affecting the lower third of the oesophagus.

It was first realised that diagnoses of adenocarcinoma were increasing rapidly in several regions of the world in the mid-1980s. But the reasons behind this dramatic increase still remain something of an enigma.

In a bid to identify any discernible patterns, the authors looked at data from 16 population based cancer registries in eight countries, going back between 29 and 54 years.

The eight countries comprised Australia, Denmark, England, Finland, Norway, Scotland, Sweden and the US.

They calculated the rates of the disease that would be expected to be diagnosed, according to the age of the population and looked at the timelines to see if there were particular flash points at which diagnoses suddenly increased.

They found that the incidence of oesophageal adenocarcinoma continued to increase rapidly in all 16 registries, and there is little evidence that this trend is beginning to plateau.

Men continue to be between three and nine times as likely to develop the disease as women—a pattern that has remained consistent over time.

Although experienced at different periods, with a gap of around 30 years, in around half the registers, a low and seemingly stable rate of new diagnoses shifted abruptly to a rapidly and consistently linear increase.

In the remainder of the registries, the rate had gone beyond a low and stable phase, and was already rising when registration started.

The timeline analysis indicated that the first discernible surge probably occurred around 1960 in Scotland and England, with a similar surge in the US starting in the mid-1970s, and another beginning in 1991 in Sweden, the last country among those studied, to experience this.

The authors suggest that as the analysis was restricted to countries and regions with reliable and longstanding data, it seems unlikely that more than a fraction of these patterns could be attributable to mistakes in correctly identifying the cases.

And as there has been little change in the proportion of patients with localised disease or death rates, changes in diagnostic accuracy are unlikely to explain the trends either.

Obesity, which is linked to acid reflux—a well known cause of the disease—has been rising rapidly too, but the pattern does not fully match that of oesophageal adenocarcinoma, say the authors, nor does it explain the gender difference seen in this type of cancer.

Smoking, an increase in acid reflux, and a fall in Helicobacter pylori infections have all probably played a part in rising incidence, say the authors. But they add: "They are unlikely to explain either the abrupt change or the astounding rate of increase."

And they conclude: "Therefore, it seems reasonable to hypothesise that the effects of a strong, highly prevalent and yet unidentified causal factor—first introduced in the UK in the middle of the 20th century—have been superimposed on the effects of known risk factors."

Explore further: Erosive, but not nonerosive, GERD ups esophageal CA risk

More information: A global assessment of the oesophageal adenocarcinoma epidemic, Online First, doi:10.1136/gutjnl-2012-302412

Related Stories

Erosive, but not nonerosive, GERD ups esophageal CA risk

April 26, 2012
(HealthDay) -- Patients with gastroesophageal reflux disease with a history of esophagitis are at increased risk for esophageal adenocarcinoma, although the absolute risk is low, according to a study published in the May ...

Prevalence of acid reflux has increased by half over the past decade

January 5, 2012
The prevalence of acid reflux experienced at least once a week has increased by almost 50%  over the past decade, NTNU researchers report in a long term study of almost 80,000 people published online in Gut.

Study finds liver cancer increasing in low risk countries, decreasing in high risk countries

October 6, 2011
A new study finds liver cancer incidence rates continue to increase in some low-risk parts of the world such as North America, and are decreasing in some of the highest risk countries of Asia. Despite this, the incidence ...

Recommended for you

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

'Labyrinth' chip could help monitor aggressive cancer stem cells

September 21, 2017
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. ...

Drug combination may improve impact of immunotherapy in head and neck cancer

September 21, 2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers ...

Whole food diet may help prevent colon cancer, other chronic conditions

September 21, 2017
A diet that includes plenty of colorful vegetables and fruits may contain compounds that can stop colon cancer and inflammatory bowel diseases in pigs, according to an international team of researchers. Understanding how ...

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Poliovirus therapy induces immune responses against cancer

September 20, 2017
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.